AuriVerse: Precision-Engineered Chemical Space for Accelerated Discovery
AuriVerse is Aurigene’s next-generation virtual chemical library—designed to enable high-quality hit identification and seamless translation into real-world execution. It combines curated chemical intelligence, AI-driven design, and Aurigene’s integrated discovery capabilities to accelerate the journey from virtual exploration to validated molecules.
The Discovery Need
From overwhelming chemical space to a synthesis-ready starting point — three engineered moves.
What Sets Aurigene Apart
Seven engineered pivots that move chemistry from possibility to validated outcome.
-
01
Superior Quality Pivot
AuriVerse is built on a quality-first philosophy where molecules are pre-filtered for drug-likeness, synthetic tractability, and absence of liabilities such as PAINS. This improves hit rates and reduces downstream attrition.
-
02
Reaction Novelty Pivot
Proprietary reaction-driven design enables access to novel chemical matter beyond conventional libraries, unlocking differentiated scaffolds and stronger IP potential.
-
03
BioSolveIT Integration
Seamless exploration-to-execution workflow enables users to navigate billions of compounds and directly initiate synthesis workflows.
-
04
Guaranteed Delivery Pivot
~60% synthesis success and 6–8 week delivery timelines ensure reliable translation from virtual hits to physical compounds.
-
05
Integrated Discovery Advantage
Combines virtual screening, medicinal chemistry, and synthesis within Aurigene to accelerate hit-to-lead progression.
-
06
Decision Intelligence Layer
Guided prioritization through design intelligence helps focus on high-probability candidates and reduces experimental burden.
-
07
Customized Virtual Library
Tailored libraries aligned to specific targets such as GPCRs, transcription factors, and ion channels.
What Sets Aurigene Apart
Seven
engineered
pivots that
move chemistry
from possibility
to validated
outcome
Superior Quality Pivot
AuriVerse is built on a quality-first philosophy where molecules are pre-filtered for drug-likeness, synthetic tractability, and absence of liabilities such as PAINS. This improves hit rates and reduces downstream attrition.
Reaction Novelty Pivot
Proprietary reaction-driven design enables access to novel chemical matter beyond conventional libraries, unlocking differentiated scaffolds and stronger IP potential.
BioSolveIT Integration
Seamless exploration-to-execution workflow enables users to navigate billions of compounds and directly initiate synthesis workflows.
Guaranteed Delivery Pivot
~60% synthesis success and 6–8 week delivery timelines ensure reliable translation from virtual hits to physical compounds.
Integrated Discovery Advantage
Combines virtual screening, medicinal chemistry, and synthesis within Aurigene to accelerate hit-to-lead progression.
Decision Intelligence Layer
Guided prioritization through design intelligence helps focus on high-probability candidates and reduces experimental burden.
Customized Virtual Library
Tailored libraries aligned to specific targets such as GPCRs, transcription factors, and ion channels.
From Virtual Space to Real Molecules
AuriVerse enables seamless transition from virtual screening to synthesis and optimization, reducing fragmentation and accelerating discovery.
Future of Discovery
AuriVerse aligns with Aurigene’s vision of connected, AI-driven discovery — integrating chemical design, data intelligence, and experimental validation into one continuum.
Accelerate your drug discovery with AuriVerse
Get Started with AuriVerse
Explore the updated AuriVerse space today and unlock the next breakthrough in your drug discovery journey!
You are about to leave Aurigene Pharmaceutical Services and affiliates website. Aurigene Pharmaceutical Services assumes no responsibility for the information presented on the external website or any further links from such sites. These links are presented to you only as a convenience, and the inclusion of any link does not imply endorsement by Aurigene Pharmaceutical Services.
If you wish to continue to this external website, click Proceed.
Leaving already?
Don't forget to join us at
CPHI Worldwide 2023.
October 24th-26th, 2023 | Barcelona, Spain
Get ready to accelerate your drug’s journey to the market